MRI and X-ray of osteosarcoma of the distal femur/Source: Mount Sinai Medical Cente
Dr. James Wittig, Chief of Orthopedic Oncology and Sarcoma Surgery at Mount Sinai in New York, knows that most patients with bone and soft tissue sarcomas don’t require amputation. Chemotherapy and surgical advances have made the difference.
Photo source: RRY Publications
Extremity product companies have done it again—after losing some momentum in previous quarters, the market is back on track with increased revenue growth rates. As the third quarter ends, the industry moves ever closer to the $1billion mark in annual revenue.
Extremity Device Companies
What does “extremities” really mean? Ask five different companies and you will likely hear five different answers. In order to truly compare companies’ market shares, do we need a standard definition of extremities?
Photo source: RRY Publications
Many orthopedists are not sufficiently focused on radiation exposure, a vital issue for patients and doctors. According to one experts, 95% of physicians grossly underestimate how much radiation exposure both they and their patients are getting.
Rouelette table from Silja Galaxy, Source: Wikimedia Commons
Economic recession? Poor growth rates in the large joints sector? Those odds don’t look good. Yet the extremity product market held on to double-digit growth rates. Read it here.
"Elbows", source: Google Images
The elbow is exploding, say our experts. With more research, mentors, and opportunities than ever, the elbow is gaining ground in the world of orthopedics.
Wikimedia Commons
Although still relatively new to the U.S., reverse shoulder replacements are gaining popularity faster than anyone expected. What makes this procedure great and which companies are helping its rise to fame? Find out here.